Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Italian risk-sharing agreements on drugs: are they worthwhile?

Literature DB >> 24728513

Italian risk-sharing agreements on drugs: are they worthwhile?

Livio Garattini¹, Alessandro Curto, Katelijne van de Vooren.

Abstract

Mesh：

Year: 2015 PMID： 24728513 DOI： 10.1007/s10198-014-0585-5

Source DB: PubMed Journal: Eur J Health Econ ISSN： 1618-7598

× No keyword cloud information.

3 in total

1. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.

Authors: Louis P Garrison; Adrian Towse; Andrew Briggs; Gerard de Pouvourville; Jens Grueger; Penny E Mohr; J L Hans Severens; Paolo Siviero; Miguel Sleeper
Journal: Value Health Date: 2013-07-19 Impact factor: 5.725

2. Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

Authors: Adrian Towse; Louis P Garrison
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

3. Risk sharing agreements: what lessons from Italy?

Authors: Livio Garattini; Gianluigi Casadei
Journal: Int J Technol Assess Health Care Date: 2011-03-24 Impact factor: 2.188

3 in total

11 in total

1. Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Authors: Livio Garattini; Alessandro Curto; Nick Freemantle
Journal: Pharmacoeconomics Date: 2016-05 Impact factor: 4.981

2. Reimbursable drug classes and ceilings in Italy: why not only one?

Authors: Livio Garattini; Alessandro Curto; Anna Padula
Journal: Eur J Health Econ Date: 2016-11

3. Performance-Based Agreements in Italy: 'Trendy Outcomes' or Mere Illusions?

Authors: Livio Garattini; Alessandro Curto
Journal: Pharmacoeconomics Date: 2016-10 Impact factor: 4.981

Review 4. The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments.

Authors: Fernando Antonanzas; Carmelo Juárez-Castelló; Reyes Lorente; Roberto Rodríguez-Ibeas
Journal: Pharmacoeconomics Date: 2019-12 Impact factor: 4.981

5. A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems.

Authors: Entela Xoxi; Filippo Rumi; Panos Kanavos; Hans-Peter Dauben; Iñaki Gutierrez-Ibarluzea; Olivier Wong; Guido Rasi; Americo Cicchetti
Journal: Front Med Technol Date: 2022-06-16

6. Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

Authors: Pedro N Aguiar; Benjamin Haaland; Wungki Park; Pui San Tan; Auro Del Giglio; Gilberto de Lima Lopes
Journal: JAMA Oncol Date: 2018-08-01 Impact factor: 31.777

7. The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

Authors: Alessandra Ferrario; Diāna Arāja; Tomasz Bochenek; Tarik Čatić; Dávid Dankó; Maria Dimitrova; Jurij Fürst; Ieva Greičiūtė-Kuprijanov; Iris Hoxha; Arianit Jakupi; Erki Laidmäe; Olga Löblová; Ileana Mardare; Vanda Markovic-Pekovic; Dmitry Meshkov; Tanja Novakovic; Guenka Petrova; Maciej Pomorski; Dominik Tomek; Luka Voncina; Alan Haycox; Panos Kanavos; Patricia Vella Bonanno; Brian Godman
Journal: Pharmacoeconomics Date: 2017-12 Impact factor: 4.981